Dewhurst Sally M, McGranahan Nicholas, Burrell Rebecca A, Rowan Andrew J, Grönroos Eva, Endesfelder David, Joshi Tejal, Mouradov Dmitri, Gibbs Peter, Ward Robyn L, Hawkins Nicholas J, Szallasi Zoltan, Sieber Oliver M, Swanton Charles
Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.
Centre for Mathematics & Physics in the Life Sciences & Experimental Biology (CoMPLEX), University College London, Physics Building, Gower Street, London WC1E 6BT, UK.
Cancer Discov. 2014 Feb;4(2):175-185. doi: 10.1158/2159-8290.CD-13-0285. Epub 2014 Jan 19.
The contribution of whole-genome doubling to chromosomal instability (CIN) and tumor evolution is unclear. We use long-term culture of isogenic tetraploid cells from a stable diploid colon cancer progenitor to investigate how a genome-doubling event affects genome stability over time. Rare cells that survive genome doubling demonstrate increased tolerance to chromosome aberrations. Tetraploid cells do not exhibit increased frequencies of structural or numerical CIN per chromosome. However, the tolerant phenotype in tetraploid cells, coupled with a doubling of chromosome aberrations per cell, allows chromosome abnormalities to evolve specifically in tetraploids, recapitulating chromosomal changes in genomically complex colorectal tumors. Finally, a genome-doubling event is independently predictive of poor relapse-free survival in early-stage disease in two independent cohorts in multivariate analyses [discovery data: hazard ratio (HR), 4.70, 95% confidence interval (CI), 1.04-21.37; validation data: HR, 1.59, 95% CI, 1.05-2.42]. These data highlight an important role for the tolerance of genome doubling in driving cancer genome evolution.
Our work sheds light on the importance of whole-genome–doubling events in colorectal cancer evolution. We show that tetraploid cells undergo rapid genomic changes and recapitulate the genetic alterations seen in chromosomally unstable tumors. Furthermore, we demonstrate that a genome-doubling event is prognostic of poor relapse-free survival in this disease type.
全基因组加倍对染色体不稳定性(CIN)和肿瘤进化的作用尚不清楚。我们使用来自稳定二倍体结肠癌祖细胞的等基因四倍体细胞进行长期培养,以研究基因组加倍事件如何随时间影响基因组稳定性。在基因组加倍后存活下来的罕见细胞对染色体畸变表现出更高的耐受性。四倍体细胞每条染色体的结构或数量性CIN频率并未增加。然而,四倍体细胞中的耐受性表型,加上每个细胞中染色体畸变数量的加倍,使得染色体异常在四倍体细胞中特异性进化,重现了基因组复杂的结直肠癌中的染色体变化。最后,在多变量分析中,基因组加倍事件在两个独立队列中可独立预测早期疾病无复发生存期较差[发现数据:风险比(HR),4.70,95%置信区间(CI),1.04 - 21.37;验证数据:HR,1.59,95% CI,1.05 - 2.42]。这些数据突出了基因组加倍耐受性在驱动癌症基因组进化中的重要作用。
我们的工作揭示了全基因组加倍事件在结直肠癌进化中的重要性。我们表明四倍体细胞经历快速的基因组变化,并重现了染色体不稳定肿瘤中所见的基因改变。此外,我们证明基因组加倍事件可预测这种疾病类型的无复发生存期较差。